David Sinclair· PhD
"They also restored key heterochromatin markers like H3K9me3 and reduced inflammatory gene programs linked to aging."
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
"They also restored key heterochromatin markers like H3K9me3 and reduced inflammatory gene programs linked to aging."
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
"The team found that boosting a protein called SIRT6 restored youthful chromatin organization in old mouse cells, reversing major age-related gene activity changes."